Deleterious effects of sleep-disordered breathing on the heart and vascular system

Respiration

Volumn 73, Issue 1, 2006, Pages 124-130

  Dincer, H Erhan ^a   O'Neill, William ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Continuous positive airway pressure; Hypertension; Sleep apnea

Indexed keywords

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; BLOOD CLOTTING DISORDER; CARDIOVASCULAR SYSTEM; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; HEART; HEART ARRHYTHMIA; HEART FUNCTION; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOXEMIA; LUNG VENTILATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; STROKE; THORAX PRESSURE;

ARRHYTHMIA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; ENDOTHELIUM, VASCULAR; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; MYOCARDIAL INFARCTION; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; SYNDROME; VENTRICULAR DYSFUNCTION;

EID: 33644540526     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089814     Document Type: Review

References (88)

1. Young T, Palta M, Dempsey J, et al: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235.
2. Ancoli-Israel S, Klauber MR, Stepnowsky C, et al: Sleep-disordered breathing in African-American elderly. Am J Respir Crit Care Med 1995;152:1946-1949.
3. Redline S: Epidemiology of sleep-disordered breathing. Semin Respir Crit Care Med 1998;19:113-122.
4. Meoli AL, Casey KR, Clark RW, Clinical Practice Review Committee, et al: Hypopnea in sleep-disordered breathing in adults. Sleep 2001;24:469-470.
5. Findley L, Unverzagt M, Guchu R, et al: Vigilance and automobile accidents in patients with sleep apnea or narcolepsy. Chest 1995;108:619-624.
6. Findley L, Bonnie RJ: Sleep apnea and auto crashes: what is the doctor to do? Chest 1988;94:225-226.
7. Rodenstein DO: Sleep apnea syndrome: the health economics point of view. Monaldi Arch Chest Dis 2000;55:404-410.
8. Worsnop CT, Naughton MT, Barter CE, et al: The prevalence of obstructive sleep apnea in hypertensives. Am J Respir Crit Care Med 1998;157:111-115.
9. Gislason T, Almqvist M: Somatic diseases and sleep complaints: an epidemiologic study of 3,201 Swedish men. Acta Med Scand 1987;221:475-481.
10. Pepperell JCT, Ramdassigh-Dow S, Crosthawite N, et al: Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomized parallel study. Lancet 2001;359:204-210.
11. Fletcher EC: Sympathetic overactivity in the etiology of hypertension of obstructive sleep apnea. Sleep 2003;1:15-19.
12. Wolk R, Shamsuzzaman ASM, Somers VK: Obesity, sleep apnea and hypertension. Hypertension 2003;42:1067-1074.
13. Brooks D, Horner RL, Kozar LF, et al: Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997;99:106-109.
14. Bao G, Metreveli N, Fletcher EC, et al: Acute and chronic blood pressure response to recurrent acoustic arousal in rats. Am J Hypertens 1999;12:504-510.
15. Nieto FJ, Young TB, Lind BK, et al: Association of sleep-disordered breathing, sleep apnea and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000;283:1829-1836.
16. Young T, Peppard PE, Palta M, et al: Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997;157:1746-1752.
17. Peppard PE, Young T, Palta M, et al: Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med 2000;342:1378-1384.
18. Logan AG, Tkacova R, Tisler A, et al: High prevalence of unrecognized obstructive sleep apnea in drug-resistant hypertension. J Hypertens 2001;19:2271-2277.
19. Hirshkowitz M, Karaca I, Gurakar A, et al: Hypertension, erectile dysfunction and occult sleep apnea. Sleep 1989;12:223-232.
20. Mayer J, Becker H, Brandenburg U, et al: Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology 1991;79:84-92.
21. Wilcox I, Grunstein RR, Hedner JA, et al: Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep 1993;16:539-544.
22. Somers VK, Dyken ME, Clary MP, et al: Sympathetic neural mechanism in obstructive sleep apnea. J Clin Invest 1995;96:1897-1904.
23. Dursuno N, Dursuno D, Cuhadaro C, et al: Acute effects of automated continuous positive airway pressure in patients with sleep apnoea and hypertension. Respiration 2005;72:150-155.
24. Monasterio C, Vidal S, Duran J, et al: Effectiveness of continuous positive airway pressure in mild sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001;164:939-943.
25. Fletcher EC, Miller J, Schaaf JW, et al: Urinary cathecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 1987;98:772-776.
26. Tkacova R, Rankin F, Fitzgerald FS, et al: Effects of nasal continuous positive airway pressure in obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 1998;98:2269-2275.
27. Grunstein R, Wilcox I, Yang TS, et al: Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Dis 1993;17:533-540.
28. Becker HF, Jerrentrup A, Ploch T, et al: Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73.
29. Elmasry A, Lindberg E, Berne C, et al: Sleep disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001;249:153-161.
30. Schulz R, Mahmoudi S, Hattar K, et al: Enhanced released of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000;162:566-570.
31. Dyugovskaya L, Lavie P, Lavie L: Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002;165:934-939.
32. Carlson JT, Rangemark C, Hedner JA, et al: Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 1996;14:577-584.
33. Kato M, Robert-Thomson P, Phillips BG, et al: Impairment of endothelium-dependent vasodilatation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000;102:2607-2610.
34. Phillips BG, Narkiewicz K, Pesek CA, et al: Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999;17:61-66.
35. Ip MS, Lam B, Chan LY, et al: Circulating nitric oxide is suppressed in obstructive sleep apnea and reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 2000;162:2166-2171.
36. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-126.
37. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al: Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002;105:2462-2464.
38. Ohga E, Nagase T, Tomita T, et al: Increased levels of circulating ICAM-1, VCAM-1 and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 1999;87:10-14.
39. El-Solh AA, Mador MJ, Sikka P, et al: Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 2002;121:1541-1547.
40. Harsch IA, Schahin SP, Radespiel-Troger M, et al: Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004;169:156-162.
41. Harsch IA, Schain SP, Bruckner K, et al: The effects of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 2004;71:252-259.
42. Yokoe T, Minoguchi K, Matsuo H, Oda N, et al: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreasing by nasal continuous positive airway pressure. Circulation 2003;107:1129-1134.
43. Nachtman A, Stang A, Wang Y, et al: Association of obstructive sleep apnea and stenotic artery disease in ischemic stroke patients. Atherosclerosis 2003;169:301-307.
44. D'Alessandro R, Magelli C, Gamberini G, et al: Snoring every night as a risk factor for myocardial infarction: a case-control study. BMJ 1990;300:1557-1558.
45. Peker Y, Karaiczi H, Hedner J, et al: An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999;14:179-184.
46. Peker Y, Hedner J, Karaiczi H, et al: Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000;162:81-86.
47. Mooe T, Franklin KA, Wiklund U, et al: Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. Chest 2000;117:1597-1602.
48. Franklin KA, Nilsson JB, Sahlin C, et al: Sleep apnoea and nocturnal angina. Lancet 1995;345:1085-1087.
49. Hanly P, Sasson Z, Zuberi N, et al: ST segment depression during sleep in obstructive sleep apnea. Am J Cardiol 1993;71:1341-1345.
50. Mooe T, Rabben T, Wiklund U, et al: Sleep-disordered breathing in women: occurrence and association with coronary artery disease. Am J Med 1996;101:251-256.
51. Mooe T, Rabben T, Wiklund U, et al: Sleep-disordered breathing in men: occurrence and association with coronary artery disease. Am J Med 1996;109:959-963.
52. Shahar E, Whitney CW, Redline S, et al: Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25.
53. Schafer H, Koehler U, Ewig S, et al: Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999;92:79-84.
54. Newman AB, Spiekerman CF, Enright P, et al: Daytime sleepiness predict mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group. J Am Geriatr Soc 2000;48:115-123.
55. Mohsenin V, Valor R: Sleep apnea in patients with hemispheric stroke. Arch Phys Med Rehabil 1995;76:71-76.
56. Wessendorf TE, Teschler H, Wang YM, et al: Sleep-disordered breathing among patients with first-ever stroke. J Neurol 2000;247:41-47.
57. Bassetti C, Aldrich MS: Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep 1999:22;217-223.
58. Hu FB, Willett WC, Manson JE, et al: Snoring and risk of cardiovascular disease in women. J Am Coll Cardiol 2000;35:308-313.
59. Silvestrini M, Rizzoto B, Placidi F, et al: Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke 2002;33:1782-1785.
60. Netzer N, Werner P, Jachums T, et al: Blood flow of the middle cerebral artery with sleep-disordered breathing correlation with obstructive hypopneas. Stroke 1998;29:87-93.
61. Hoffstein V, Mateika S: Cardiac arrhythmia, snoring and sleep apnea. Chest 1994;106:466-471.
62. Disler P, Hansford A, Skelton J, et al: Diagnosis and treatment of obstructive sleep apnea, in a stroke rehabilitation unit: a feasibility study. Am J Phys Med Rehabil 2002;81:622-625.
63. Guilleminault C, Connolly SJ, Winkle RA: Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983;52:490-494.
64. Javaheri S, Parker TJ, Liming JD, et al: Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences and presentations. Circulation 1998;97:2154-2159.
65. Shepard JW, Garison MW, Grither DA, et al: Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 1985;88:335-340.
66. Becker H, Brandenburg U, Peter JH, et al: Reversal of sinus arrest and atrioventricular conduction block in patients with sinus arrest during nasal continuous positive airway pressure. Am J Respir Crit Care Med 1995;151:215-218.
67. Koehler U, Fus E, Grimm W, et al: Heart block in patients with obstructive sleep apnoea: pathogenic factors and effects of treatment. Eur Respir J 1998;11:434-439.
68. Gillis AM, Stoohs R, Guilleminault C, et al: Changes in QT interval during obstructive sleep apnea. Sleep 1991;14:346-350.
69. Javaheri S: Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000;101:392.
70. Garrigue S, Bordier P, Jais P, et al: Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med 2002;346:404-412.
71. Alchanatis M, Tourkohoriti G, Kosmas EN, et al: Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J 2002;20:1239-1245.
72. Cloward TV, Walker JM, Farney RJ, Anderson JL: Left ventricular hypertrophy is a common echocardiographic abnormality in severe obstructive sleep apnea and reverses with nasal continuous positive airway pressure. Chest 2003;124:594-601.
73. Laaban JP, Pascal-Sebaoun S, Bloch E, et al: Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest 2002;122:1133-1138.
74. Fung JW, Li TS, Choy DK, Yip GW, et al: Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest 2002;121:422-429.
75. 2 and respiratory delay. Circulation 2001;103:238-243.
76. Weitzenblum E, Krieger J, Apprill, et al: Day-time pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 1988;138:345-349.
77. Chaouat A, Weitzenblum E, Krieger J, et al: Pulmonary hemodynamics in the obstructive sleep apnea syndrome. Results in 220 consecutive patients. Chest 1996;109:380-386.
78. Sanner BM, Doberauer C, Konermann M, et al: Pulmonary hypertension in patients with obstructive sleep apnea syndrome. Arch Intern Med 1997;157:2483-2487.
79. Sajkov D, Cowie RJ, Thornton AT, et al: Pulmonary hypertension and hypoxemia in obstructive sleep apnea. Am J Respir Crit Care Med 1994;149:416-422.
80. Bady E, Achkar A, Pascal S, et al: Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Thorax 2000;55:934-939.
81. Atwood SW, McCrory D, Garcia JG, et al: Pulmonary artery hypertension and sleep-disordered breathing. Chest 2004;126:72S-77S.
82. Gozal D, Lipton AJ, Jones KL, et al: Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 2002;25:59-65.
83. Lavie L, Kraiczi H, Hefetz A, et al: Plasma vascular endothelial growth factor in obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure treatment. Am J Respir Crit Care Med 2002;165:1624-1628.
84. Alchanatis M, Tourkohoriti G, Kakouros S, et al: Daytime hypertension in patients with obstructive sleep apnea: the effect of continuous positive airway pressure on pulmonary hemodynamics. Respiration 2001;68:566-572.
85. Sajkov D, Wang T, Saunders NA, et al: Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002;165:152-158.
86. Sanner BM, Konermann M, Sturm A, et al: Right ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J 1997;10:2079-2083.
87. Berman EJ, DiBenedetto RJ, Causey DE, et al: Right ventricular hypertrophy detected by echocardiography in patients with newly diagnosed obstructive sleep apnea. Chest 1991;100:347-350.
88. Nahmias J, Lao R, Karetzky M, et al: Right ventricular dysfunction in obstructive sleep apnoea: reversal with nasal continuous positive airway pressure. Eur Respir J 1996;9:945-951.